| + |
CCL5 | up-regulates
|
Metastasis |
0.7 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-277729 |
|
|
Homo sapiens |
Pancreatic Cancer Cell |
| pmid |
sentence |
| 38339310 |
This suggests CCL5 not only remodels the PDAC TME to benefit tumor cells, but can also enhance the tumor cell’s metastatic potential. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IRX2 | down-regulates quantity by repression
transcriptional regulation
|
CCL5 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-266043 |
|
|
Homo sapiens |
Hs-578T Cell |
| pmid |
sentence |
| 26560478 |
Our results imply that the IRX2 transcription factor might represent a novel metastasis associated protein that acts as a negative regulator of cellular motility and as a repressor of chemokine expression. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
maraviroc | down-regulates
chemical inhibition
|
CCL5 |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-194127 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| Other |
|
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
CCL5 | up-regulates
binding
|
CCR3 |
0.768 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-254370 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 10734056 |
In addition to the CCR1 receptor, RANTES activates several members of the CC subfamily of chemokine receptors including CCR3, CCR4, and CCR5 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
CCL5 | down-regulates quantity by repression
post transcriptional regulation
|
hsa-miR-199a-5p |
0.4 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-278863 |
|
|
Homo sapiens |
JJ012 Cell |
| pmid |
sentence |
| 25444917 |
These results suggest that CCL5 promotes VEGF-dependent angiogenesis and tumor growth by downregulating miR-199a in vivo. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
FOXP3 | up-regulates quantity by expression
transcriptional regulation
|
CCL5 |
0.434 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-277727 |
|
|
Homo sapiens |
Pancreatic Cancer Cell |
| pmid |
sentence |
| 38339310 |
Given its role as a potent chemoattractant for T cells, CCL5 can be utilized to attract Tregs to malignant epithelial cells. Wang et al. demonstrated that Forkheadbox protein 3 (FOXP3), a key transcription factor for Tregs, was highly ex- pressed in pancreatic cancer cell lines, which, in turn, upregulated CCL5 expression |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
CCL5 | up-regulates
binding
|
CCR1 |
0.772 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-254367 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 10734056 |
RANTES interacts with specific cell surface receptors, which are coupled to pertussis toxin-sensitive guanine nucleotide regulatory proteins (G protein) to activate effectors such as phospholipase C (PLC), ion channels, phospholipase D, and protein kinase C. In addition to the CCR1 receptor, RANTES activates several members of the CC subfamily of chemokine receptors including CCR3, CCR4, and CCR5 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
CCL5 | up-regulates activity
binding
|
CCR5 |
0.937 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-277726 |
|
|
Homo sapiens |
Pancreatic Cancer Cell |
| pmid |
sentence |
| 38339310 |
CCL5, also known RANTES (regulated on activation, normal T cell expressed and secreted), is a potent chemoattractant for a variety of leukocytes, including T cells, mono- cytes, NK cells, and basophils, signaling via the CCR1, CCR3, and CCR5 cell surface receptors [59]. Among these receptors, CCL5 has the highest affinity for CCR5. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
CCL5 | down-regulates quantity by repression
post transcriptional regulation
|
hsa-miR-200b-5p |
0.4 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-278865 |
|
|
Homo sapiens |
JJ012 Cell |
| pmid |
sentence |
| 25301739 |
CCL5 enhances VEGF-dependent angiogenesis in human chondrosarcoma cells by down-regulating miR-200b through PI3K/Akt signaling pathway. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |